Search Results

Path to the Podium: Advice for Early Career Physicians

Insights on how to refine your interests, strengthen your expertise, and step confidently onto the podium.

With Merve Ozen, MD, and Parag J. Patel, MD, MS, FSIR

Renal Ablation: Can We Push the Treatment Boundaries?

Strategies for treatment based on size criteria, ablation modality, tumor location, periprocedural considerations, and combination therapy options.

By Ronak Patel, BS, and Merve Ozen, MD

Interventional Oncology: Exploring the Boundaries

By Edward Kim, MD, FSIR

DEBATE: What Does the Current Evidence on EVAR for Ruptured AAA Tell Us?

Robert J. Hinchliffe, MD, FRCS, and Janet T. Powell, MD, PhD, FRCPath, compare perspectives with Frank J. Veith. MD, and Caron B. Rockman, MD.

The Evolution of Vascular Surgery

Endovascular Today interviews Giorgio M. Biasi, MD, President of the ISVS, who discusses the worldwide mission of the society and the state of vascular surgery.

BCLC Staging and Treatment Algorithm: Does It Cover All?

The Barcelona Clinic Liver Cancer staging system is a commonly used algorithm for the management of HCC; however, there are key deviations in contemporary practice.

By Altan Ahmed, MD, MSc; Richard Kim, MD; Daniel A. Anaya, MD, MSHCT, FACS; and Bela Kis, MD, PhD, FSIR

Ask the Experts: Which Factors Have the Most Influence on Your Decision-Making Regarding the Treatment of Perforators?

Leading venous practitioners share their treatment algorithms for when it is appropriate to intervene on perforator veins and when it is not.

With Melvin Rosenblatt, MD; Sergio Gianesini, MD, PhD, FACS; Ellen D. Dillavou, MD, FACS; Thomas Proebstle, MD; and Kathleen Gibson, MD, FACS

Dissection Retrospective: Progress Since the INSTEAD Trial

Lessons learned from the first randomized trial comparing TEVAR and optimal medical therapy for type B aortic dissection.

By Christoph A. Nienaber, MD, PhD, FESC, FAHA

Where Will the Vascular Interventions of the Future Be Performed in the US?

Insights into the evolving landscape of care locations and facility types.

With Ehrin J. Armstrong, MD, MSc, MAS, FACC, FSCAI, FSVM; Sonya Noor, MD, FACS; Mary Costantino, MD; and David M. Mauro, MD

Commentary: Staying on Course

Obtaining the highest level of evidence in interventional oncology requires that we stay on course and strive for positive prospective randomized trials.

By Nadine Abi-Jaoudeh, MD

Coil Embolization of Type II Endoleak

Moderator: Kimberly Malka, MD, PhD;
Panelists: Clayton J. Brinster, MD; Bill Parkhurst, MD; and Jessica P. Simons, MD, MPH

Hybrid Thoracic Aneurysm Repair

Combination surgical and EVAR approaches for treating arch and descending thoracic aneurysms.

By Roy K. Greenberg, MD, and Lars Svensson, MD, PhD

Top Tips in Interventional Oncology

Clinical and technical insights into treating hepatocellular carcinoma, cholangiocarcinoma, renal cell carcinoma, lung cancer, bone cancer, and in the palliative care setting.

By Siddharth A. Padia, MD; Theodore Bryan, MD; Rebecca Bennett, MD; Nadine Abi-Jaoudeh, MD, FSIR, CCRP; Raul N. Uppot, MD; Robert Suh, MD; Paul I. Mallinson, MBChB, FRCR, FRCPC; Peter L. Munk, MDCM, FRCPC, FSIR, FFRRCSI (Hon); Miyuki Sone, MD; and Yasuaki Arai, MD, FSIR, FCIRSE